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Abstract
Purpose Oocyte vitrification does not affect embryo quality
after oocyte warming, making this method effective in the
preservation of female fertility. Morphokinetic parameters
can be used to predict the competence of an embryo produced
from fresh oocytes. Our aim was to study the effect of oocyte
vitrification on zygote-embryo kinetics (pl).
Methods The embryo-kinetics of fresh and sibling vitrified/
warmed oocytes were compared to determine the conse-
quences of oocyte preservation on the timing of embryo de-
velopment. A 44-hours time-lapse analysis, from the time of
ICSI (t0), of 179 fertilized fresh oocytes was compared to 168
fertilized sibling vitrified/warmed oocytes.
Results Oocyte vitrification accelerated pronuclear disappear-
ance, one-cell stage timing and modified nucleoli activity by
increasing their number and decreasing their diameter at the
zygote stage. In contrast, embryo kinetics during cleavage
were similar to those observed for fresh sibling oocytes based
on the parameters examined in this study.
Conclusions At the zygote stage, oocyte vitrification induces
changes in pronuclei stability, probably due to pronuclei
envelop instability as well as modifications in nucleoli func-
tionality. Therefore, the predictive morphokinetic parameters
on embryo competence found from fresh oocytes must be
revised when applied on embryos from vitrified/warmed
oocytes.
Keywords Embryo-kinetic . Oocyte . Time-lapse .
Vitrification . Zygote
Introduction
The aim of oocyte cryopreservation is to preserve oocyte in-
tegrity by exposure to very low temperatures thus arresting
biological activity until clinical use. Oocyte freezing is effec-
tive for fertility preservation in oncological patients, for egg
donation programs, or to delay pregnancy for medical or so-
cial reasons [21]. In Italy, this technology has beenwidespread
for several years due to a severe regulation that prohibited the
production and freezing of surplus embryos for each cycle of
in vitro fertilization [24, 15].
The two methods used for oocyte cryopreservation are
slow cooling followed by rapid thawing [12, 25, 4] and vitri-
fication followed by rapid warming [19, 16]. The first method
resulted in numerous pregnancies. However, the technical ad-
vances in vitrification, especially with the introduction of the
Cryotop method, where the cell is immersed in a very small
volume of cryoprotectant (0.1 μl), together with ultra-rapid
cooling and thawing rates, made oocyte vitrification the wide-
ly preferred method due to higher oocyte survival [18, 23, 14,
3] and higher pregnancy rates, when compared to the slow
freezing/rapid thawing method [7].
From the cellular point of view, we previously laid out that
oocyte slow freezing/rapid thawing protocol induces a
Capsule At the zygote stage, oocyte vitrification induces changes in
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as modifications in nucleoli functionality. The predictive morphokinetic
parameters on embryo competence found from fresh oocytes must be
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significant decrease in cleavage rate and embryo quality com-
pared to sibling fresh oocytes [8]. On the contrary, a similar
study have shown that fresh and sibling vitrified/warmed oo-
cytes have similar embryo quality, cleavage and clinical preg-
nancy rates [26].
Oocyte cryopreservation has consequences at molecular level.
The mRNA content is decreased by 60.6 % in slowly frozen/
rapidly thawed oocytes and 36.7 % in vitrified/warmed oocytes
when comparedwith fresh oocytes [9]. The decrease ofmRNA is
particularly relevant for mRNA of proteins involved in cell cycle
regulation and processes, energetic pathway and DNA structural
organization. These results gave an explanation of the differences
of in vitro and clinical outcomes according to the method of
oocyte cryopreservation.
Over the last few years, the introduction of time-lapse tech-
nology in the IVF laboratory has led to a multitude of studies
that linked embryo-kinetics with the competence to develop and
implant (see for review [29]). Recently, we proposed a method
for the routine use of morphokinetic parameters to the aim of
identifying embryos that have competence of developing and
implanting within the first 3 days of in vitro culture [10].
In the present study, fresh and vitrified/warmed oocytes
produced from the same ovarian stimulation (same patients),
were processed for intracytoplasmic sperm injection (ICSI)
and the embryos from both groups were cultured under iden-
tical conditions. For these reasons the kinetics of embryos
produced from fresh and sibling vitrified/warmed oocytes
are fully comparable to determine the consequences of oocyte
cryopreservation on the timing of embryo development. The
results will help understand whether informative
morphokinetic parameters, previously determined on embryos
produced from fresh oocytes, are also applicable for embryos
produced from vitrified/warmed oocytes, or how they should
be recalculated.
Material and methods
Population, ICSI, oocyte cryopreservation and embryo culture
The studied group is a mix of 47 patients aged between 29 and
39 years (mean age 34.1 years), with basal FSH between 2 and
11 IU/l (mean 6.4 IU/l) having undergone ICSI protocol after
ovarian stimulation.
The ICSI technique has previously been described [8] and
was performed as follows: All patients underwent ICSI treat-
ment with fresh or vitrified/thawed oocytes and fresh ejacu-
lated spermatozoa. Ovarian stimulation was achieved by the
administration of luteal gonadotrophin-releasing hormone an-
alogue (GnRHa) (Suprefact: Hoechst Marion Roussel
Deutschland GmbH, Frankfurt, Germany) followed by re-
combinant FSH (Gonal-F: Merck-Serono, London, UK or
Puregon, MSD, Franklin Lakes, USA) from cycle day 3.
Vaginal ultrasound-guided aspiration of oocyte – cumulus
complex was performed 35 h after human chorionic gonado-
trophin administration (HCG 10,000 IU, Gonasi: AMSA,
Rome, Italy). Oocyte denudation was performed 2 h after
oocyte retrieval. ICSI on fresh oocytes was performed 1 h after
oocyte denudation. After ICSI, in vitro culture was carried out
in 25 μl of HTF cleavage Quinn’s medium (SAGE, Trumbull,
USA) under mineral oil until day 3 (4–8 cells stage) in auto-
mated incubators with 5 % CO2, 5 % O2 at 37 °C, fitted with
time-lapse imaging acquisition (Embryoscope, Unisense, Aar-
hus, Denmark). When embryo culture was prolonged after
day 3, in vitro culture media was changed to HTF blastocyst
Quinn’s medium (SAGE). During the incubation in the
Embryoscope, five plane focal images were generated every
7 min and recorded. The kinetics of embryo development was
recorded and reported for 44 h post-ICSI.
All patients gave written consent to freeze surplus meta-
phase II (MII) oocytes. The MII oocytes for freezing or fresh
treatment were randomly chosen. The vitrification protocol
used to freeze and thaw oocytes has been previously described
[9]. Oocyte vitrification was started immediately after oocyte
denudation. ICSI was performed 1 h after in vitro culture of
vitrified/warmed oocytes.
For each couple, ICSI on fresh and vitrifed/warmed oo-
cytes was performed using two fresh sperm samples from
the male patient. The semen characteristics were similar in
the two samples (sperm concentration, percentages of mor-
phologically normal sperm and motile sperm). ICSI was per-
formed with motile and morphologically normal spermatozoa.
Definition of kinetic criteria
The definition and nomenclature of morphokinetic parameters
recently published by a consensus of time-lapse user group
were applied [13]. Time t0 was defined as the time of ICSI.
Time t2PB was defined as the time of the completed second
polar body detachment from the oolemma. Time tPNa was
defined as the time of the first frame in which both pronuclei
could be observed. Time tC was the frame with the last obser-
vation of both pronuclei. From this time, the nucleolus pre-
cursor bodies decreased in size and subsequently disappeared,
followed by pronuclei membrane flattening. The successive
frame, corresponding to one cell stage was annotated as tPNf.
Finally, t2, t3 and t4 were defined as the times for the corre-
sponding number of cells (t2 for 2 cells, etc.). The times were
annotated at the first frame in which the cells (blastomeres)
were seen as separated by individual membranes.
The difference tPNa-t2PB was the duration between the
second polar body detachment and the appearance of both
pronuclei. The difference tC-tPNa was the duration of time
with both pronuclei (2PN) visualized. The difference tPNf-
tC was the duration of pronuclei fading, in other words the
time for complete nucleoli and then pronuclei envelop
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disappearance. The first round of cleavage was defined cc1
and it was calculated as t2-tPNf; the second round of cleavage
was defined cc2 and it was calculated as t3-t2.
An additional parameter assessed was the synchronization
of cell division(s), i.e. the time required for each blastomere to
replicate and reach the successive cell cycle. The synchroni-
zation parameters were defined as s2 (calculated as t4-t3). All
times were expressed in hours and fractions of an hour.
With a concern of data-homogeneity and because part of
the embryos were transferred on day 2–3 and others on day 5,
we decided to not include in the present study the morpho-
kinetic parameters after t4 (day 2).
Study of nucleoli
At tC, the number and diameter of nucleoli were calculated in
both pronuclei in zygotes from fresh and vitrified/warmed
oocytes. The nucleoli diameter was measured using
Embryo-Viewer (Unisense).
Statistical analysis
All analyzed data were continuous variables. The hypothesis
about distributions of post-ICSI timings (t2PB, tPNa, tC,
tPNf, t2, t3 and t4) and calculated timings (tPNa-t2PB, tC-
tPNa, tPNf-tC, cc1, cc2, and s2) of embryos from two groups
(embryos produced from fresh oocytes and embryos produced
from vitrified/warmed oocytes) were tested by the two-sample
Kolmogorov-Smirnov non-parametric tests. In both cases,
each group was taken as an independent sample. Because of
non-normal distribution, the medians were compared by
Kruskall-Wallis non-parametric test.
The Z-test was used to establish different significance
levels (p<0.05; <0.001) between ratios.
All procedures were approved by the institutional review
board of Unità diMedicina della Riproduzione – Istituto HERA.
Results
In vitro results
On fresh treatments, 253 MII oocytes were micro-injected.
Surplus 270 MII oocytes were vitrified and warmed in a suc-
cessive ICSI treatment. 239 of the warmed oocytes survived
(survival rate: 88.5 %) and were micro-injected with fresh
ejaculated partner sperm. In Table 1, in vitro results of ICSI
on fresh and vitrified/warmed oocytes are detailed.
Results, in terms of fertilization and cleavage rates and the
proportion of 2 multi-nucleated cells at the 2-cell stage were
comparable in fresh and vitrified/warmed oocytes. The pro-
portion of 2-cell stage embryos without multinucleated cells
was higher in embryos from vitrified/warmed oocytes (78.5 %
from fresh oocytes versus 87.5 % from vitrified/warmed oo-
cytes, p<0.05). The first cell division resulted in 2 even cells
more frequently in embryos from fresh oocytes (97.8% versus
93.5 %, p<0.05). The percentage of 2-cell stage embryos
reaching 3- and 4-cell stages were significantly inferior from
vitrified/warmed oocytes (100 % versus 93.5 %; p<0.001 and
97.2 % versus 87.9 %; p<0.001 respectively).
Kinetic results
The distribution of the timings t2PB, tPNa, tC, tPNf, t2, t3 and t4
and the calculated timings tPNa-t2PB, tC-tPNa, tPNf-tC, cc1 and
cc2 were not normally distributed (Kolmogorov-Smirnov non
parametric test, p-value < 0.05). The non-parametric Kruskall-
Wallis showed no significant differences for the variable t2PB,
tPNa and the calculated timing tPNa- t2PB, cc2 and s2 (p-value >
0.05), but significant differences (p<0.05) for the variables tC,
tPNf, t2, t3 and t4 and the calculated timings of tC-tPNa, tPNf-
tC and cc1 were observed. Kinetic data are described in Table 2.
The morphokinetic parameters of zygotes and embryos
from fresh and vitrified/warmed oocytes in the studied popu-
lation are shown in Fig. 1.
Nucleoli analysis
At tC, the mean number of nucleoli was 4.1 [1;9] in pronuclei
from fresh oocytes and 5.3 [1;11] in pronuclei from vitrified/
warmed oocytes. The respective mean diameter of nucleoli
was 3.1 and 2.6 μm in zygotes from fresh and vitrified/
warmed oocytes. Figure 2 compares the nucleoli configura-
tion in zygotes from fresh and vitrified/warmed oocytes.
Discussion
From the present data, there is no difference in t2PB and tPNa
between zygotes produced from fresh and sibling vitrified/
warmed oocytes. Oocyte vitrification induced an anticipation
of tC and tPNf in zygotes generated from vitrified/warmed
oocytes compared to fresh sibling oocytes. The variations of
these timings have as consequence the shortening of 2PN
appearance (tC-tPNa) duration and cc1 in zygotes and embry-
os from vitrified/warmed oocytes. The timings t2, t3 and t4 are
accelerated in the embryos generated from vitrified/warmed
oocytes due to the shift of the previous phases (zygote stage).
In the meantime, tPNa-t2PB, cc2 and s2 are not statistically
different between embryos produced from fresh and sibling
vitrified/warmed oocytes. In other words, it can be said that
oocyte vitrification has no consequence on the completion of
oocyte meiosis as demonstrated by the absence of variations
of t2PB and the duration tPNa-t2PB between zygotes from
fresh and sibling vitrified/warmed oocytes. On the contrary,
oocyte vitrification has effects on the fertilization process and
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the first embryo mitosis events, as described by the decrease
of the phases from the duration of observable 2PN until 2-cell
stage. From 2-cell stage, the embryo kinetics are comparable
in length and independent of oocyte source.
The shortening of tC-tPNa duration in vitrified/warmed
oocytes could be due to pronuclei envelop instability (early
evanescence), a problem of cytoskeleton traction (the
pronuclei do not abut), or nucleoli functionality (nucleoli fade
before agglomerating). From our data, we could not obtain
information from the spatial organization of pronuclei within
the zygotes measuring the distance at tC (just before PN fad-
ing) because two pronuclei were overlapped in 45.0 % of the
zygotes and the distance between them could not be appreci-
ated. By counting and measuring the diameter of nucleoli
before tC, we found that the mean number of nucleoli was
higher (5.3 versus 4.1) and their diameter was smaller
(2.6 μm versus 3.1 μm) in zygotes from vitrified/warmed
oocytes compared to zygotes from fresh oocytes, suggesting
an early evanescence of nucleoli before they complete ag-
glomeration in zygotes from cryopreserved oocytes. In respec-
tively 17.9 % (32/179) and 25.6 % (43/168, p>0.05) of the
zygotes from fresh and vitrified/warmed oocytes, the differ-
ence of number of nucleoli between the two pronuclei and
before PN fading was more than 2. According to Scott et al.
[27], the presence of small scattered and unequal-sized nucle-
oli, as observed in zygotes from vitrified/warmed oocytes,
could be indicative of functional defects with subsequent de-
creased and ineffective synthesis of rRNA. Recently, it has
Table 2 Morphokinetic data from fresh and vitrified/warmed oocytes
Fresh oocytes Vitrified/warmed oocytes
n Mean DS Median Intervals n Mean DS Median Intervals pKS1 pKW1
t2PB 179 3.1 0.7 3.0 1.8;4.6 168 3.4 1.1 3.2 1.9;6.7 0.000 0.062
tPNa 179 7.7 1.5 7.5 4.7;11.2 168 8.3 2.5 7.6 4.6;14.2 0.000 0.125
tC 179 25.2 5.3 23.9 16.5;43.4 168 23.0 2.8 23.0 17.6;30.4 0.000 0.001
tPNf 179 26.1 5.8 24.6 17.0;46.8 168 23.6 2.8 23.4 18.1;30.7 0.000 0.001
t2 179 29.0 6.2 27.5 19.2;52.1 168 26.9 3.4 26.9 20.7;37.9 0.000 0.007
t3 179 39.4 6.9 38.6 23.6;60.1 157 37.1 5.1 37.4 25.2;52.7 0.006 0.014
t4 174 41.5 6.4 40.2 30.0;67.4 138 39.2 5.0 39.4 28.0;60.0 0.000 0.002
tPNa-tPB2 179 4.2 1.4 4.0 1.4;7.7 168 4.6 2.1 4.3 4.1;10.0 0.003 0.144
tC-tPNa 179 17.5 5.3 16.0 9.0;36.1 168 14.7 3.5 15.1 6.5;23.7 0.000 0.000
tPNf-tC 179 0.8 1.0 0.7 0.2;7.0 168 0.6 0.4 0.5 0.2;2.5 0.000 0.038
cc1(t2-tPNf) 179 3.5 3.5 2.7 1.3;25.1 168 3.3 1.7 2.8 2.0;13.2 0.000 0.000
cc2 (t3-t2) 179 10.3 4.5 11.9 0.0;17.7 157 10.6 4.6 12.0 0.0;20.2 0.000 0.460
s2 (t4-t3) 174 2.0 3.1 1.0 0.0;11.3 138 2.3 3.7 0.7 0.0;14.3 0.000 0.907
pKS1 p value after Kolmogorov-Smirnov test, pKW1 p value after Kruskall-Wallis test
Table 1 In vitro results of ICSI with fresh and vitrifed/warmed oocytes
Fresh oocytes Vitrifed/warmed oocytes p
n. cycles 47 47 –
n. micro-injected oocytes (%) 253 239 –
n. 2PN (% on micro-injected oocytes) 179 (70.8) 168 (70.3) ns
2 cells-stage (% on 2PN) 179 (100) 168 (100) ns
No multinucleation at 2C stage (% on 2C stage) 140 (78.2) 147 (87.5) <0.05
1 multinucleated cell at 2C stage (% on 2C stage) 35 (19.6) 18 (10.7) <0.05
Both multinucleated cells at 2C stage (% on 2C stage) 4 (2.2) 4 (2.4) ns
2 even cells at 2C stage (% on 2C stage) 175 (97.8) 157 (93.5) <0.05
2 uneven cells at 2C stage (% on 2C stage) 4 (2.2) 11 (6.5) <0.05
3 cells-stage (% on 2C stage) 179 (100) 157 (93.5) <0.001
4 cells-stage (% on 2C stage) 174 (97.2) 138 (87.9) <0.001
The statistical significances between treatments with fresh and sibling vitrified/warmed oocytes (p) were compared with z-test
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been demonstrated that the fusion of nucleoli is regulated by
mitogen-activated protein kinase (MAPK) and maturation-
promoting factor (MPF) [20]. The early nucleoli fading before
nucleoli fusion could be due to MAPK and MPF activity
dysregulation in zygotes from vitrified/warmed oocytes.
After sperm penetration, DNA synthesis starts synchro-
nously within male and female pronuclei at about 12 h after
sperm-oocyte fusion to reach the diploid one-cell stage at tPNf
[5]. From our data, we cannot exclude that the DNA synthesis
process would be disturbed by oocyte freezing because the
modifications of kinetic are observed properly during DNA
synthesis period (before tPNf). Further DNA analysis of
arrested zygotes and embryos produced from vitrified/
warmed oocytes could be informative.
Many articles have underlined the use of morphokinetic pa-
rameters for the determination of competent embryos [22, 11, 10,
17, 6]. In some studies, the very early morphokinetic parameters
before cleavage stage have been determined as being informative.
Azzarello et al. [2] used the time of pronuclei breakdown (corre-
sponding here to tPNf) as a morphokinetic parameter predictive
for embryo implantation. Aguilar et al. [1] defined the timings of
second polar body extrusion, pronuclear fading and the duration S
(corresponding here to tC-tPNa) as predictive factors of embryo
competence. We previously determined tPNf and tC-tPNa to be
informative on the day-3 embryo competence to become a viable
blastocyst on day 5 of in vitro culture [10]. The present study
shows for the first time how much a laboratory procedure such
as oocyte vitrification can modify the morphokinetic parameters
at zygote stage.
In a previous publication performed on fresh oocytes [10]
we determined the morphokinetic parameters that are infor-
mative on the embryo competence to reach blastocyst stage on
day 5 (IVD-MPK) and to implant when transferred (IMP-
MKP). We also compared our results with those already pub-
lished and underlined the necessity of each laboratory to de-
termine its own informative parameters in its conditions of
work. From the results reported here from vitrified/warmed
oocytes, we observe an anticipation of tC and tPNf and all
the successive timings even if cc2 and s2 remain unchanged.
Under our working conditions, we should verify if the previ-
ous IVD-MKP and IMP-MKP remain valid on embryos pro-
duced from vitrified/warmed oocytes. We will have to take in
consideration that the timing t2, t4, t7 and t8 could be shifted
because of the anticipations of tC and tPNf. It will be interest-
ing to observe how the previous determined ‘IVD-MKP’ tC-
tF (corresponding here to tC-tPNa) would vary for competent
embryos. In 2 embryos from vitrified/warmed oocytes that
reached blastocyst stage on day 5 and implanted when trans-
ferred, the IVD-MKP tC-tPNa was shorter than the 7.7 h low-
er limit previously determined on embryos from fresh oocytes.
All the other IVD-MKP and IMP-MKP were within the pre-
viously described ranges [10].
In the present study we show for the first time that oocyte
vitrification has consequences on embryo kinetic at the zygote
stage. Oocyte vitrification has no consequence on embryo
kinetics at cleavage stage. The study of morphokinetic param-
eters is confirmed as a valid methodology for the determina-
tion of variation of embryo-kinetics generated by a procedure/
protocol in the IVF laboratory. Furthermore, the retrospective
time-lapse monitoring study gives the possibility of an in-
depth analysis of a specific morphological trait such as nucle-
oli count and dimension before pronuclei fading.
In 2013, the practice committees of the ASRM and SART
stated that oocyte vitrification and warming should no longer
be considered experimental, and fertilization and pregnancy
rates are similar to IVF/ICSI with fresh oocytes when vitrified/
Fig. 2 Nucleoli organization prior to pronuclei fading in zygote from
fresh (a) and sibling vitrified/warmed (b) oocytes
Fig. 1 Embryokinetic from fresh
oocytes and sibling vitrified/
warmed oocytes from time 0 to
44 h
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warmed oocytes are used as part of IVF/ICSI in young infer-
tility patients and oocyte donor [28]. Nevertheless, the com-
parative study of fresh and sibling vitrified/warmed oocyte
highlights that oocyte vitrification induces a moderate de-
crease of mRNA content [9] and a modification of zygote
kinetic.
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